ABL1 and acute lymphoblastic leukemia: RNA-Seq is particularly useful for identifying oncogenic fusion transcripts, such as BCR::ABL1 in CML or ETV6::RUNX1 in ALL, which may not be detected by DNA-based sequencing methods.